Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7540549 [patent_doc_number] => 08058392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895946 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10355 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058392.pdf [firstpage_image] =>[orig_patent_app_number] => 12895946 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895946
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 6149311 [patent_doc_number] => 20110020906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/896041 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10359 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020906.pdf [firstpage_image] =>[orig_patent_app_number] => 12896041 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/896041
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 6149310 [patent_doc_number] => 20110020905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/895967 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10362 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020905.pdf [firstpage_image] =>[orig_patent_app_number] => 12895967 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895967
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 7545583 [patent_doc_number] => 08053555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895955 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10328 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053555.pdf [firstpage_image] =>[orig_patent_app_number] => 12895955 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895955
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 6149307 [patent_doc_number] => 20110020902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/895933 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10363 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020902.pdf [firstpage_image] =>[orig_patent_app_number] => 12895933 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895933
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 7515511 [patent_doc_number] => 08039583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895899 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10355 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039583.pdf [firstpage_image] =>[orig_patent_app_number] => 12895899 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895899
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 6196558 [patent_doc_number] => 20110028316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/896061 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10356 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028316.pdf [firstpage_image] =>[orig_patent_app_number] => 12896061 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/896061
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 7515512 [patent_doc_number] => 08039584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895904 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10381 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039584.pdf [firstpage_image] =>[orig_patent_app_number] => 12895904 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895904
Carbon nanotube binding peptides Sep 30, 2010 Issued
Array ( [id] => 6120643 [patent_doc_number] => 20110077164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'EXPRESSION PROFILING PLATFORM TECHNOLOGY' [patent_app_type] => utility [patent_app_number] => 12/889935 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9574 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077164.pdf [firstpage_image] =>[orig_patent_app_number] => 12889935 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/889935
EXPRESSION PROFILING PLATFORM TECHNOLOGY Sep 23, 2010 Abandoned
Array ( [id] => 5977592 [patent_doc_number] => 20110071046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'MATRIX SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 12/888862 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10948 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071046.pdf [firstpage_image] =>[orig_patent_app_number] => 12888862 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/888862
MATRIX SCREENING METHOD Sep 22, 2010 Abandoned
Array ( [id] => 6083648 [patent_doc_number] => 20110144031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same' [patent_app_type] => utility [patent_app_number] => 12/923463 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4732 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144031.pdf [firstpage_image] =>[orig_patent_app_number] => 12923463 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/923463
Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same Sep 22, 2010 Abandoned
Array ( [id] => 7818502 [patent_doc_number] => 20120065122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Pharmaceutical Composition and Method for Modulating Slow Myosin' [patent_app_type] => utility [patent_app_number] => 12/882546 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 1866 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065122.pdf [firstpage_image] =>[orig_patent_app_number] => 12882546 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/882546
Pharmaceutical Composition and Method for Modulating Slow Myosin Sep 14, 2010 Abandoned
Array ( [id] => 6000644 [patent_doc_number] => 20110117073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Protein Kinase Conjugates and Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/882484 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 42036 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117073.pdf [firstpage_image] =>[orig_patent_app_number] => 12882484 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/882484
Protein kinase conjugates and inhibitors Sep 14, 2010 Issued
Array ( [id] => 6389872 [patent_doc_number] => 20100317837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES' [patent_app_type] => utility [patent_app_number] => 12/869198 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17725 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317837.pdf [firstpage_image] =>[orig_patent_app_number] => 12869198 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/869198
IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES Aug 25, 2010 Abandoned
Array ( [id] => 5986706 [patent_doc_number] => 20110098235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'ANTINEOPLASTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/869314 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6584 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098235.pdf [firstpage_image] =>[orig_patent_app_number] => 12869314 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/869314
Antineoplastic peptides Aug 25, 2010 Issued
Array ( [id] => 9983791 [patent_doc_number] => 09029505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Modified vasoactive intestinal peptides' [patent_app_type] => utility [patent_app_number] => 12/857103 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13714 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12857103 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/857103
Modified vasoactive intestinal peptides Aug 15, 2010 Issued
Array ( [id] => 6136138 [patent_doc_number] => 20110009291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'METHODS AND COMPOSITIONS FOR INCREASING MEMBRANE PERMEABILITY' [patent_app_type] => utility [patent_app_number] => 12/846646 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14547 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009291.pdf [firstpage_image] =>[orig_patent_app_number] => 12846646 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/846646
METHODS AND COMPOSITIONS FOR INCREASING MEMBRANE PERMEABILITY Jul 28, 2010 Abandoned
Array ( [id] => 5959531 [patent_doc_number] => 20110183918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Method of Treating Leukemia Using Rcie Prolamin' [patent_app_type] => utility [patent_app_number] => 12/845039 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4726 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183918.pdf [firstpage_image] =>[orig_patent_app_number] => 12845039 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/845039
Method of Treating Leukemia Using Rcie Prolamin Jul 27, 2010 Abandoned
Array ( [id] => 6183444 [patent_doc_number] => 20110123448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'OIL BODY CARRIERS, USES IN TARGET THERAPY AND/OR DETECTION OF THE SAME, AND FUSION PROTEINS COMPRISED THEREIN' [patent_app_type] => utility [patent_app_number] => 12/841500 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 9993 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123448.pdf [firstpage_image] =>[orig_patent_app_number] => 12841500 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/841500
OIL BODY CARRIERS, USES IN TARGET THERAPY AND/OR DETECTION OF THE SAME, AND FUSION PROTEINS COMPRISED THEREIN Jul 21, 2010 Abandoned
Array ( [id] => 5993477 [patent_doc_number] => 20110015130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/838926 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 11976 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015130.pdf [firstpage_image] =>[orig_patent_app_number] => 12838926 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/838926
Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof Jul 18, 2010 Abandoned
Menu